RIFAXIMINA NELLA CIRROSI: UN’OTTIMA REVIEW DEL GRUPPO INTERNAZIONALE CON PAOLO CARACENI E PAOLO ANGELI
The Use of Rifaximin in Patients With Cirrhosis Paolo Caraceni et al. Abstract Rifaximin is an oral nonsystemic antibiotic with minimal gastrointestinal absorption and broad-spectrum antibacterial activity covering both gram-positive and gram-negative organisms. Rifaximin is currently used worldwide in patients with cirrhosis for preventing recurrent HE because its efficacy and safety have been proven by…